Pharmaceutical

Sutro strengthens its immuno-oncology pipeline with two new ADCs

In June, Sutro received a $140m payment from Blackstone Life Sciences as part of the Vaxcyte product licensing agreement.

Aug 12, 2023 - 20:00
Sutro strengthens its immuno-oncology pipeline with two new ADCs
In June, Sutro received a $140m payment from Blackstone Life Sciences as part of the Vaxcyte product licensing agreement.
Read the original article

Tags:

Previous Article

Clinigen clears out cancer therapies in line with latest growth strategy

Next Article

Signal: Wave of layoffs in medical start-ups exposes underlying vulnerability

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Syros Pharmaceuticals gets grant for CDK7 inhibitors for treating cancer and other diseases

Syros Pharmaceuticals gets grant for CDK7 inhibitors fo...

Jun 12, 2024

Pumping breastmilk in bathrooms is a common, albeit unspoken, practice at health care conferences

Pumping breastmilk in bathrooms is a common, albeit uns...

Jan 18, 2024

Results from Rybrevant trial solidify Janssen’s foothold in EGFR-mutated NSCLC

Results from Rybrevant trial solidify Janssen’s foothol...

Sep 13, 2023